Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Nanoparticle Formulation : SOP for Supercritical Fluid Techniques for Nanoparticle Preparation

Posted on By

SOP for Supercritical Fluid Techniques for Nanoparticle Preparation

Standard Operating Procedure for Supercritical Fluid Techniques in Nanoparticle Preparation

1) Purpose

This SOP outlines the use of supercritical fluid techniques for the preparation of nanoparticles, which allow for controlled particle size and purity. The supercritical fluid method is commonly used to prepare drug nanoparticles with enhanced solubility.

2) Scope

This SOP applies to all laboratory personnel involved in the use of supercritical fluids for the preparation of nanoparticles.

3) Responsibilities

  • Operators: Responsible for following the supercritical fluid technique protocol accurately.
  • QA: Ensures that nanoparticles prepared using supercritical fluids meet the required quality standards.

4) Procedure

4.1 Setup of Supercritical Fluid Apparatus

4.1.1 Equipment Preparation

  • 4.1.1.1 Ensure that the supercritical fluid apparatus is cleaned, calibrated, and properly set up according to the manufacturer’s guidelines.
  • 4.1.1.2 Check for leaks and ensure that all safety protocols are in place for handling supercritical CO2 or other fluids.
See also  SOP for Preparation of Nanoparticles for Nasal Delivery

4.1.2 Solvent and Drug Preparation

  • 4.1.2.1 Dissolve the drug or active ingredient in a solvent appropriate for the supercritical fluid process (e.g., ethanol, acetone).
  • 4.1.2.2 Set up the drug solution and supercritical fluid for introduction into the apparatus.

4.2 Supercritical Fluid Process

4.2.1 Introduction of Supercritical Fluid

  • 4.2.1.1 Slowly introduce the supercritical fluid (e.g., CO2) into the system at the specified temperature and pressure conditions.
  • 4.2.1.2 Ensure that
the flow rates of both the drug solution and supercritical fluid are consistent and as per the process requirement.

4.2.2 Particle Formation

  • 4.2.2.1 As the supercritical fluid expands, nanoparticles are formed as the solvent evaporates and the drug precipitates.
  • 4.2.2.2 Collect the formed nanoparticles in the collection chamber.

4.3 Washing and Drying

4.3.1 Washing with Solvent

  • 4.3.1.1 Wash the nanoparticles using a suitable solvent to remove any residual supercritical fluid or impurities.

4.3.2 Drying of Nanoparticles

  • 4.3.2.1 Dry the nanoparticles under vacuum or in a desiccator to ensure complete removal of solvent residues.

4.4 Characterization

4.4.1 Particle Size Analysis

  • 4.4.1.1 Use dynamic light scattering (DLS) or similar techniques to measure the particle size of the nanoparticles.
  • 4.4.1.2 Record the particle size and ensure it meets the required specifications.

4.5 Storage of Nanoparticles

4.5.1 Storage Conditions

  • 4.5.1.1 Store the nanoparticles in sterile, sealed containers and maintain them at room temperature or 4°C depending on the stability of the formulation.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • CO2: Carbon Dioxide
  • QA: Quality Assurance

6) Documents, if any

  • Supercritical Fluid Process Logbook

7) References, if any

  • Relevant literature on supercritical fluid techniques in nanoparticle preparation

8) SOP Version

Version 1.0

Annexure

Supercritical Fluid Process Logbook Template

Date Batch Number Fluid Used Particle Size Encapsulation Efficiency Operator Initials QA Initials
DD/MM/YYYY Batch Number Fluid (e.g., CO2) Size in nm % Encapsulation Operator Name QA Name
           
See also  SOP for Preparation of Lipid-Based Nanoparticles
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Selection and Preparation of Solvents for Lyophilized Formulations
Next Post: Lyophilized Products : SOP for Preparation of Buffers for Lyophilized Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version